Healthcare technology company Symplr, backed by Clearlake Capital, is in the midst of a single-asset secondaries deal, PE Hub reports. The secondaries process comes after Symplr returned to market earlier this year with Evercore, Goldman Sachs and William Blair exploring transactions including a stake sale, as PE Hub reported in June. Charlesbank made a minority investment in Symplr in a deal that valued the company in the range of $3.3 billion to $3.5 billion. Read more.
Related Posts
Commons Clinic Harvests $11M Seed Round
Bass Ventures led, and was joined by Oxeon Partners.
December 13, 2022
Prosser Memorial Health Plans New $78M Hospital Complex in Washington State
A $57.5 million loan from the U.S. Department of Agriculture will help Prosser Memorial build a new hospital complex this year.
March 1, 2022
Eleos Health Raises $6M in Seed Round
aMoon Fund led the round and was joined by investors including lool ventures.
September 13, 2021
Healthwell Acquisition I Raises $250M in IPO
The new SPAC has said it will pursue technology-enabled companies across the healthcare industry.
August 3, 2021